Treatment Registry
TR-0187 ActiveRecorded September 2, 2026

Brand tirzepatide

Sold by NowPatient · Injection, pen · every brand tirzepatide record

What you actually pay

Per month

$251.98

Medication · Mounjaro, lowest dose (2.5mg/0.5mL), medication price; shipment/duties billed separately$251.98

Added from the figures recorded below.

Price

TermPer monthCharged today
Mounjaro, lowest dose (2.5mg/0.5mL), medication price; shipment/duties billed separately

2.5mg/0.5mL, 1 KwikPen 5mg/0.5mL, 1 KwikPen 7.5mg/0.5mL, 1 KwikPen 10mg/0.5mL, 1 KwikPen 12.5mg/0.5mL, 1 KwikPen 15mg/0.5mL, 1 KwikPen Price $251.98 Shipment & duties $75.00

source

Per month$251.98Charged today$251.98
Visit NowPatient

We earn nothing from this link. NowPatient has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberLive visit
Cancellation“By law, consumers in the European Union have the right to cancel a contract for the purchase of an item within fourteen working days of the day of receipt of the order.”
MembershipOptional. $9.99 per month. “The Core+ plan is NowPatient's premium membership tier, priced at £9.99 per month (UK) or $9.99 per month (US and Rest of the World), billed monthly. Core+ gives you the same access to all the features available through the Core plan, but now with unlimited usage of AI and health tracking tools. Free shipping is also included for treatments or prescription supplies.”

Not yet checked: pharmacy, states and consult fee.

Recorded from nowpatient.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0187
Readings
1

Related records

What else NowPatient sells

All NowPatient programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NowPatient brand tirzepatide (TR-0187). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0187

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.